PPIs and the Treatment of GERD, Dyspepsia and NSAID-associated Peptic Ulcer Disease
Credits: (up to) 1.5 credit hours

Login


New User? Please Register
Forgot Password / User ID?
Accreditation:

This course has been accreditated for:

  • MainPro M1
Description:

The aim of this course is to increase general practitioners’, family physicians’ and other healthcare practitioners’ awareness of PPIs in the management of upper GI conditions including GERD, peptic ulcer disease and dyspepsia.

Learning Objectives include:

  1. Understanding the role of double-dose PPI therapy and comparing various PPIs and their effects on clinically important outcomes.
  2. Recognizing clinical scenarios where PPIs may be inappropriately utilized and re-assessing medication therapy.
  3. Defining the role of PPI therapy in the treatment of asthma and laryngeal symptoms.
  4. Understanding the complications of Long-Term PPI Use.
Sponsored by: Canadian Optimal Medication Prescribing and Utilization Service (COMPUS)
COMPUS is a directorate of the Canadian Agency for Drugs and Technologies in Health (CADTH)

Course Offerings:
Session: 1
Information: Cost: $0.00
Status: You must log in to register for this session.
Facilitator: Dr. Laura Targownik

Privacy Policy | Disclaimer | FAQ |